Taevas
BangladeshMedical Devices
Imports & Shipments
Imports & Shipments for Medical Devices in Bangladesh
Taevas Global helps medical devices manufacturers navigate DGDA registration, customs clearance, and end-to-end shipment logistics to establish a compliant, scalable presence in Bangladesh's fast-growing healthcare market.
Market
Bangladesh
Industry
Medical Devices
Service
Imports & Shipments
Regulator
Directorate General of Drug Administration (DGDA)
Timeline
6-12 weeks for full clearance
What We Deliver
Six Pillars of Bangladesh Medical Devices Intelligence
Our six interconnected pillars give medical devices companies the regulatory clarity, logistics infrastructure, and market intelligence needed to import and ship compliantly into Bangladesh.
01
DGDA Regulatory Mapping
We decode the full DGDA registration and import permit framework for medical devices, including the Medical Device Regulation 2022 requirements. Our team identifies the exact classification, documentation, and approval pathway for your specific product category. This eliminates guesswork and prevents costly delays at Chittagong or Dhaka ports.
Product classification under DGDA schedules
Import permit and no-objection certificate guidance
Medical Device Regulation 2022 compliance checklist
How It Works
From Brief to Board-Ready Intelligence
Our four-step engagement moves from initial scoping through deep regulatory and logistics research to a final deliverable and live debrief, keeping your team informed and in control at every stage.
Step 1 · Day 1-2
Intake & Scoping
We begin with a structured intake call to understand your product portfolio, target device categories, intended end-users, and existing regulatory status in your home market. This session captures the specific import and shipment challenges you are facing in Bangladesh. The output is a scoping document that defines the exact deliverables, timelines, and success criteria for your engagement.
Taevas Approach
The intake form covers product classification, current certifications such as CE or FDA clearance, intended sales channels including private hospitals, clinics, and government procurement, and any prior DGDA interactions. We use this to assign the right regulatory and logistics specialists from our Bangladesh team and to flag any immediate red flags such as product categories under import restriction or requiring special ministerial approval.
Market Snapshot
Bangladesh Medical Devices Market at a Glance
$0M+
Estimated Market Size (2024)
0%
Projected Annual Growth Rate
0+
Licensed Medical Device Importers
0%
Market Supplied by Imports
Import-Dependent Healthcare System
Bangladesh has virtually no domestic medical device manufacturing base for mid-to-high complexity products, making it almost entirely reliant on imports from China, India, Germany, the USA, and Japan. This creates a structurally open market for foreign manufacturers but also means competition is intense at the distributor level. Establishing the right local importer relationship is the single most critical market entry decision.
DGDA Regulatory Evolution
The Directorate General of Drug Administration has been progressively tightening medical device oversight since the Medical Device Regulation 2022 came into force, introducing formal registration requirements for higher-risk device classes. Manufacturers who registered early under the older, more permissive import permit system may need to re-register under the new framework. Staying ahead of DGDA's evolving guidance is essential for uninterrupted import operations.
Government Procurement as Growth Driver
The Directorate General of Health Services manages large-scale procurement of medical equipment for public hospitals and health facilities across Bangladesh, representing a significant revenue opportunity for registered foreign manufacturers. Government tenders are published through the Central Procurement Technical Unit (CPTU) and require compliant DGDA registration as a prerequisite for bid eligibility. Companies that complete regulatory registration early gain a competitive advantage in public sector sales.
Rising Private Sector Demand
Bangladesh's private hospital sector has expanded rapidly, with major groups such as Square, United, and Evercare investing in diagnostic imaging, surgical equipment, and ICU infrastructure. This segment prioritizes internationally certified products and is less price-sensitive than the public sector, making it an attractive entry point for premium medical device brands. Distributors with strong private hospital relationships command premium margins and faster payment cycles.
What's Included
Everything in Your Report
Your engagement package delivers eight structured components that give your regulatory, logistics, and commercial teams everything needed to execute imports and shipments into Bangladesh with confidence.
DGDA Registration Pathway Guide
A step-by-step guide to the DGDA medical device registration process specific to your product class, including required documents, fees, timelines, and common rejection reasons.
Import Documentation Checklist
A complete, Bangladesh-specific checklist of all import documents required by DGDA, NBR Customs, and port authorities, formatted for use by your regulatory and logistics teams.
Tariff & Duty Analysis
A detailed breakdown of applicable HS codes, import duties, supplementary duties, VAT, and advance income tax for your device category, including any available exemptions under health policy provisions.
Customs Clearance Process Map
A visual and narrative process map of the customs clearance workflow at Chittagong Port and Dhaka air cargo terminals, including inspection triggers and average clearance timelines.
Freight & Logistics Options Assessment
An evaluation of sea versus air freight options, recommended freight forwarders with medical device handling experience, cold-chain capabilities, and bonded warehouse locations near major distribution hubs.
Licensed Importer Shortlist
A curated shortlist of three to five DGDA-licensed importers or authorized representatives in your device category, with profiles covering portfolio, market reach, financial standing, and regulatory compliance history.
Risk & Compliance Flags
A prioritized register of regulatory, customs, and logistics risks specific to your product and entry strategy, with mitigation recommendations and escalation contacts.
Phased Market Entry Roadmap
A 12-month milestone plan sequencing DGDA registration, first shipment, distributor onboarding, and initial commercial launch activities aligned to Bangladesh's healthcare procurement cycles.
Who This Is For
Built for These Situations
Pre-launch
First-Time Exporter to Bangladesh
Your company has CE marking or FDA clearance and is evaluating Bangladesh as a new export market, but has no prior DGDA experience or local relationships. You need to understand the regulatory requirements, import costs, and distributor landscape before committing resources. This engagement gives you a verified, current-state picture of exactly what market entry requires.
Outcome
A clear go or no-go decision backed by real regulatory and market data, with a shortlist of qualified local partners ready to engage.
Next Steps
After Imports & Shipments, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your Bangladesh Opportunity?
Whether you are planning your first medical device shipment to Bangladesh or resolving an existing import challenge, Taevas Global gives you the regulatory clarity, logistics intelligence, and local partner access to move forward with confidence.
DGDA-specific regulatory pathway mapped to your device category
Full tariff and duty analysis with exemption identification
Vetted local importer shortlist with due diligence profiles
Board-ready 12-month market entry roadmap